You just read:

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference

News provided by

INOVIO Pharmaceuticals, Inc.

Apr 28, 2020, 16:30 ET